News

We participated in a major study within the CZECANCA project

12. 12. 2024

As part of the Czecanca project , we participated in the scientific study A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer. GHC Genetics has been a long-term active partner of the project and contributes a large amount of laboratory and clinical data.

We participated in a major study within the CZECANCA project

More info

Opening hours over the Christmas period and at the end of 2024

09. 12. 2024

23.12.2024: 7:00-17:00

24.12-26.12.2024: CLOSED

27.12.2024 7:00-16:00

30.12.2024 7:00-17:00

31.12.2024 7:00-14:00

1.1.2025 CLOSED

More info

Fundraiser for 22 million could yield therapeutic procedure to cure Angelman syndrome

06. 12. 2024

5 years ago, the parents of little Oliver, Lenka and Rado, approached a Czech scientific team within their organization Asgent with one goal - to turn the incurable disease Angelman syndrome into a curable one. And they are succeeding! The research is getting closer and closer to the goal every year. This year, the research team succeeded in creating a proposal for a functional therapeutic procedure. The road to a future cure and the first patients will still be challenging, but the Czech research team is closer than ever. But to reach sick children, they need your help. In order to turn hope into reality, we now need to raise funds to carry out preclinical tests. GHC Genetics has been a proud partner and supporter of Asgent for several years.

More info

older articles